Jingjing Liu

机构：Shenyang Pharmaceutical University, Huaqiao University, Ministry of Education of the People's Republic of China, North China University of Science and Technology, Nankai University, Northwest University, Tangshan People's Hospital, Jilin Province Tumor Hospital, University of South China · ORCID：0000-0001-8333-5233

发表论文 65 篇 · 总被引 984 次 · h-index 18

代表论文

• Sulfamate Acetamides as Self-Immolative Electrophiles for Covalent Ligand-Directed Release Chemistry (2023 · Journal of the American Chemical Society · 被引 42)
• Cellular senescence primes liver fibrosis regression through Notch‐EZH2 (2023 · MedComm · 被引 22)
• Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma (2023 · Thoracic Cancer · 被引 20)
• Expert consensus on treatment for stage III non‐small cell lung cancer (2023 · Medicine Advances · 被引 18)
• Efficacy, Safety, and Early Relapse after Cessation of Upadacitinib versus Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis®: A Real-World Study in China (2024 · Dermatitis · 被引 15)
• Indocyanine green based photodynamic therapy for keloids: Fundamental investigation and clinical improvement (2023 · Photodiagnosis and Photodynamic Therapy · 被引 14)